Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis

M Drolet, É Bénard, N Pérez, M Brisson, H Ali, MC Boily… - The Lancet, 2019 - thelancet.com
Background More than 10 years have elapsed since human papillomavirus (HPV)
vaccination was implemented. We did a systematic review and meta-analysis of the …

Population-based HPV vaccination programmes are safe and effective: 2017 update and the impetus for achieving better global coverage

JML Brotherton, PN Bloem - Best practice & research Clinical obstetrics & …, 2018 - Elsevier
Persistent oncogenic human papillomavirus (HPV) is the cause of cervical cancer, as well as
cancers of the anus, penis, vulva, vagina and oropharynx. There is good evidence that …

[HTML][HTML] Malaria surveillance—United States, 2015

KE Mace - MMWR. Surveillance Summaries, 2018 - cdc.gov
Abstract Problem/Condition: Malaria in humans is caused by intraerythrocytic protozoa of the
genus Plasmodium. These parasites are transmitted by the bite of an infective female …

[HTML][HTML] Human papillomavirus vaccination: the population impact

L Lee, SM Garland - F1000Research, 2017 - ncbi.nlm.nih.gov
We currently have the knowledge and experience to prevent much of human papillomavirus
(HPV)-related disease burden globally. In many countries where prophylactic HPV …

Global burden of head and neck cancer

QB Rahman, O Iocca, K Kufta… - Oral and …, 2020 - oralmaxsurgery.theclinics.com
Cancer refers to a group of diseases characterized by uncontrolled or unchecked division of
cells with the potential for these cells to metastasize. Cancer imparts a significant degree of …

Dose-related effectiveness of quadrivalent human papillomavirus vaccine against cervical intraepithelial neoplasia: a Danish nationwide cohort study

F Verdoodt, C Dehlendorff… - Clinical Infectious Diseases, 2020 - academic.oup.com
Background A reduced, 2-dose schedule of human papillomavirus (HPV) vaccination has
been endorsed for preadolescent women on the basis of immunogenicity data from …

[HTML][HTML] Quadrivalent HPV vaccine effectiveness against anogenital warts: A registry-based study of 2, 2 million individuals

S Nygård, M Nygård, M Orumaa, BT Hansen - Vaccine, 2023 - Elsevier
Abstract Background In 2009, Norway initiated routine quadrivalent HPV (qHPV) vaccination
for girls at 12–13 years of age to protect against virus types causing cervical cancer …

Protecting the community through child vaccination

EJ Anderson, MA Daugherty… - Clinical Infectious …, 2018 - academic.oup.com
The direct impact of vaccines on children is well described, but the major public health
impact of indirect protection provided to the community by vaccines is underappreciated …

Progress in prophylactic human papillomavirus (HPV) vaccination in 2016: A literature review

PJ Maver, M Poljak - Vaccine, 2018 - Elsevier
Prophylactic human papillomavirus (HPV) vaccine represents a revolutionary step forward in
preventing HPV-related cancers, especially cervical carcinoma. Alongside appropriate …

Incidence of anogenital warts: epidemiological risk factors and real-life impact of human papillomavirus vaccination

G Tyros, S Mastraftsi, S Gregoriou… - … journal of STD & …, 2021 - journals.sagepub.com
Anogenital warts (AGWs) rank among the most frequent sexually transmitted infections in
young adults. They are benign lesions, but they pose a significant economic cost to health …